secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2021-07-14T23:59:59+00:00
Accession:  0001628280-21-013829
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus elects Mary Kay Ladone to Board as Class II director effective July 15, 2021
--------------------------------------------------------------------------------

- Mary Kay Ladone appointed to Board, Audit and Risk Committee, and Compensation Committee.
- Ladone is SVP, Corporate Development, Strategy and IR at Hill-Rom, with prior roles at Baxalta and Baxter.
- Annual cash retainer $55,000 plus $10,000 for Audit and $7,500 for Compensation Committee service.
- Initial restricted stock unit award with aggregate fair value of $152,000, pro-rated per policy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000162828021013829/0001628280-21-013829-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000162828021013829/bvs-20210714.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-013829

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer